Fort Wayne, Ind.-based orthopedic implant company BioPoly has secured FDA approval for its new knee implant, according to an April 23 report from CBS affiliate WANE.
With the approval, the company can begin clinical trials for the device, which aims to address cartilage problems in patients with ongoing knee pain.
BioPoly has started seeking patients for the study, which is open to around 152 patients.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
